{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:09:47Z","timestamp":1776276587569,"version":"3.50.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:p>Pelvic high-grade serous carcinoma (HGSC) has been postulated to arise via a stepwise accumulation of (epi)genetic alterations from normal epithelium to secretory cell outgrowth (SCOUT), p53 signature, and serous tubal intraepithelial carcinoma (STIC) to invasive HGSC. The aim of this study is to investigate alterations in p53 and CD44v9 expression and the status of Ki-67 labeling index in a series of fallopian tube lesions of HGSC patients. A total of 45 specimens were analyzed in 16 patients with HGSC, and their lesions were categorized as follows: morphologically normal fallopian tube epithelium (FTE, n=6 samples), SCOUT (n=5), p53 signature (n=4), dormant STIC (n=8), active STIC (n=6), and HGSC (n=16). Morphologic features and immunohistochemical expression patterns of the p53 protein, CD44v9 protein, and Ki-67 antigen were blindly evaluated by 2 pathologists. Increased nuclear p53 protein accumulation was observed in p53 signature, dormant STIC, active STIC and HGSC compared with normal FTE and SCOUT (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Immunohistochemistry scores of CD44v9 protein expression were significantly higher in normal FTE, SCOUT, and p53 signature than in dormant STIC, active STIC, and HGSC (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Both active STIC and HGSC had significantly higher Ki-67 labeling indices than normal FTE, SCOUT, p53 signature and dormant STIC (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). CD44v9 loss contributes to the stepwise progression of p53 signature to dormant STIC. In conclusion, p53 mutation followed by CD44v9 loss may be involved in the evolution of STIC, which may confer positive clonal selection with a growth and survival advantage.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000738","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T02:21:28Z","timestamp":1614219688000},"page":"419-426","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma"],"prefix":"10.1097","volume":"40","author":[{"given":"Sumire","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiho","family":"Ohbayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4103\/0377-4929.191789","article-title":"Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma","volume":"59","author":"Mittal","year":"2016","journal-title":"Indian J Pathol Microbiol"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1158\/0008-5472.CAN-17-1671","article-title":"STAT3\/PIAS3 levels serve as \u201cEarly Signature\u201d genes in the development of high-grade serous carcinoma from the fallopian tube","volume":"78","author":"Saini","year":"2018","journal-title":"Cancer Res"},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/cas.13728","article-title":"High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: potential targets by sulfasalazine","volume":"109","author":"Wada","year":"2018","journal-title":"Cancer Sci"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/10715762.2017.1383605","article-title":"Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis","volume":"51","author":"Kobayashi","year":"2017","journal-title":"Free Radic Res"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J Pathol"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"3","author":"Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J Pathol"},{"key":"R14-20250802","first-page":"292","article-title":"Incessant ovulation and ovarian cancer\u2014a hypothesis re-visited","volume":"5","author":"Fathalla","year":"2013","journal-title":"Facts Views Vis Obgyn"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"848595","DOI":"10.1155\/2015\/848595","article-title":"Oxidative stress and antioxidant defense in endometriosis and its malignant transformation","volume":"2015","author":"Iwabuchi","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.tranon.2017.05.005","article-title":"SIRT1 regulates the chemoresistance and invasiveness of ovarian carcinoma cells","volume":"10","author":"Mvunta","year":"2017","journal-title":"Transl Oncol"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1111\/jog.14093","article-title":"Immunohistochemical expression of CD44v9 and 8-OHdG in ovarian endometrioma and the benign endometriotic lesions adjacent to clear cell carcinoma","volume":"45","author":"Niiro","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.2744","article-title":"The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas","volume":"222","author":"Kobel","year":"2010","journal-title":"J Pathol"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cjp2.53","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma","volume":"2","author":"Kobel","year":"2016","journal-title":"J Pathol Clin Res"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.21873\/invivo.11411","article-title":"CD44 predicts early recurrence in pancreatic cancer patients undergoing radical surgery","volume":"32","author":"Hsu","year":"2018","journal-title":"In Vivo"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PGP.0b013e31824cbeb4","article-title":"Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Kuhn","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"12609","DOI":"10.18632\/oncotarget.23035","article-title":"Reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cells","volume":"9","author":"Nakamura","year":"2018","journal-title":"Oncotarget"},{"key":"R24-20250802","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1093\/nar\/gkv111","article-title":"TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer","volume":"43","author":"Chien","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.3390\/ijms20215482","article-title":"The association and significance of p53 in gynecologic cancers: the potential of targeted therapy","volume":"20","author":"Nakamura","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1038\/onc.2012.638","article-title":"Redox regulation in stem-like cancer cells by CD44 variant isoforms","volume":"32","author":"Nagano","year":"2013","journal-title":"Oncogene"},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1158\/0008-5472.CAN-13-1803","article-title":"IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC","volume":"74","author":"Yang","year":"2014","journal-title":"Cancer Res"},{"key":"R28-20250802","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/path.4000","article-title":"MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma","volume":"228","author":"Liu","year":"2012","journal-title":"J Pathol"},{"key":"R29-20250802","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","article-title":"Integrated proteogenomic characterization of human high-grade serous ovarian cancer","volume":"166","author":"Zhang","year":"2016","journal-title":"Cell"},{"key":"R30-20250802","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/gcc.22075","article-title":"Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients","volume":"52","author":"Pedersen","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R31-20250802","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/pros.1124","article-title":"Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer","volume":"49","author":"Kito","year":"2001","journal-title":"Prostate"},{"key":"R32-20250802","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1349-7006.1999.tb00773.x","article-title":"Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line","volume":"90","author":"Sato","year":"1999","journal-title":"Jpn J Cancer Res"},{"key":"R33-20250802","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/(SICI)1097-0215(19990129)80:3<439::AID-IJC17>3.0.CO;2-V","article-title":"Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation","volume":"80","author":"Verkaik","year":"1999","journal-title":"Int J Cancer"},{"key":"R34-20250802","first-page":"1253","article-title":"Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression","volume":"12","author":"Yasui","year":"1998","journal-title":"Int J Oncol"},{"key":"R35-20250802","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5009\/gnl.2011.5.4.397","article-title":"The role of CD44 in the pathogenesis, diagnosis, and therapy of gastric cancer","volume":"5","author":"Jang","year":"2011","journal-title":"Gut Liver"},{"key":"R36-20250802","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.1002\/cam4.1874","article-title":"CD44v9 is associated with epithelial-mesenchymal transition and poor outcomes in esophageal squamous cell carcinoma","volume":"7","author":"Taniguchi","year":"2018","journal-title":"Cancer Med"},{"key":"R37-20250802","doi-asserted-by":"crossref","first-page":"4867234","DOI":"10.1155\/2018\/4867234","article-title":"Overexpression of CD44 variant 9: a novel cancer stem cell marker in human cholangiocarcinoma in relation to inflammation","volume":"2018","author":"Suwannakul","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R38-20250802","doi-asserted-by":"crossref","first-page":"19821","DOI":"10.1074\/jbc.M110.104273","article-title":"Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor","volume":"285","author":"Ghatak","year":"2010","journal-title":"J Biol Chem"},{"key":"R39-20250802","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ijc.2910570413","article-title":"Molecular mechanisms possibly affecting WT1 function in human ovarian tumors","volume":"57","author":"Viel","year":"1994","journal-title":"Int J Cancer"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:04:14Z","timestamp":1754161454000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000738","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,9]]}}}